Loading...
Neutralizing TGF-β promotes anti-tumor immunity of dendritic cells against pancreatic cancer by regulating T lymphocytes
Previous fundamental or clinical trials of dendritic cell (DC) vaccine against pancreatic ductal adenocarcinoma (PDAC) revealed the burgeoning neoadjuvant immunotherapy. Microarray studies indicated that multiple ingredients of the transfer growth factor beta (TGF-β) pathway were overexpressed in PD...
Na minha lista:
| Udgivet i: | Cent Eur J Immunol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Polish Society of Experimental and Clinical Immunology
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6102619/ https://ncbi.nlm.nih.gov/pubmed/30135623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ceji.2018.77381 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|